Rybrevant Faspro (amivantamab-lpuj 2400 MG / hyaluronidase-lpuj 30000 UNT) per 15 ML Injection

RxCUI: 2735797
RxNorm name: Rybrevant Faspro (amivantamab-lpuj 2400 MG / hyaluronidase-lpuj 30000 UNT) per 15 ML Injection
Display name: Rybrevant Faspro (amivantamab-lpuj 2400 MG / hyaluronidase-lpuj 30000 UNT) per 15 ML Injection
Full name: Rybrevant Faspro (amivantamab-lpuj 2400 MG / hyaluronidase-lpuj 30000 UNT) per 15 ML Injection
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:10

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761484	Rybrevant Faspro	amivantamab and hyaluronidase-lpuj	351(a)	Rx	2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Rybrevant Faspro	AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT)	Janssen Biotech, Inc.	9e58b045-e352-4f62-99bf-77fae1bebc69	2026-06-17	Warnings, Adverse reactions	Exact identifier rxcui: 2735797

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
9e58b045-e352-4f62-99bf-77fae1bebc69	Rybrevant Faspro 2400 MG / 30000 UNT in 15 ML Injection [PSN] · 15 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection [Rybrevant Faspro] [SBD] · Rybrevant Faspro (amivantamab-lpuj 2400 MG / hyaluronidase-lpuj 30000 UNT) per 15 ML Injection [SY] · Rybrevant Faspro 2400 MG / 30000 UNT per 15 ML Injection [SY]	4	4	These highlights do not include all the information needed to use RYBREVANT FASPRO safely and effectively. See full prescribing information for RYBREVANT FASPRO. RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) injection, for subcutaneous use Initial U.S. Approval: 2025	20260218